“The truth is that everyone is bored, and devotes himself to cultivating habits.” – Albert Camus, The Plague E-commerce For decades companies have invested billions trying to understand consumer behavior,…
psychedelics stocks 2021
Early money Generating revenue as a new company is almost always difficult. It typically takes time to build up a loyal customer base, execute marketing campaigns and create awareness…
Shamans among the machines In his 1999 lecture titled ‘Shamans Among the Machines’ Terence McKenna pointed out that “as far as people and machines are concerned, it was Ludwig…
Earlier this month I wrote a piece on Field Trip (FTRP.C) scaling their ketamine clinics after a huge $95M raise. I liked their business model, and Novamind’s (NM.C) is…
There are two options when it comes to ingesting psychedelics, natural or synthetic. People have been tripping balls eating raw natural mushrooms for thousands of years, so why…
+135k shares in a downturn, my man The psychedelics sector is down bad this week. Just look at the psychedelics ETF PSYK.NE. It’s not an alarm or…
Supersized bought deal Field Trip (FTRP.CN) announced on Friday that it raised a whopping $95.3M CAD through a bought deal. The deal was originally for proceeds of $50M CAD…
IPO’s come in all shapes and sizes, some are giants with billionaire support, and others don’t have a pitch deck readily available. Investors get giddy with news of…
Cut the kumbaya shit Throwing the words profit and psychedelic drugs into a sentence would have lead to awkward and confused looks 5 years ago. But we have come…
Humming in Q1 I’ve had a rough year, but Revive (RVV.C) sure hasn’t. With a portfolio based around psychedelics, cannabis, and diseases – this company has made 3…